ADDENDUM A TO MICHAEL J. VASCONCELLES OFFER LETTER CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 1st, 2023 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 1st, 2023 Company Industry JurisdictionThis Agreement is entered into as of the 29th day of December, 2022 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Michael Vasconcelles (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 1st, 2021 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionThis Agreement is entered into as of the 1st day of June, 2020 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Stacy A. Coen (the “Executive”).
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 5th, 2020 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 5th, 2020 Company Industry JurisdictionThis Agreement is entered into as of the 20th day of July, 2020 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Susan Altschuller (the “Executive”).